MedTrace Logo

The ECLA/PHRI Intervention in the Community Trial

NCT05638009 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2490

Last updated 2022-12-15

No results posted yet for this study

Summary

EPIC is a cluster-randomized, double-blind trial to evaluate the effect of two potassium-enriched salt substitute preparations (one available in the Argentine market and one derived from it), compared to regular salt on systolic blood pressure in subjects ≥ 18 and ≤ 90 years old from Rosario department households in Santa Fe Province, Argentina.

Conditions

Interventions

DIETARY_SUPPLEMENT

Salt substitute 66%33%

Salt substitute composed of 66% potassium chloride and 33% sodium chloride

DIETARY_SUPPLEMENT

Salt substitute 33%/66%

Salt substitute composed of 33% potassium chloride and 66% sodium chloride

Sponsors & Collaborators

  • Population Health Research Institute

    collaborator OTHER

  • Estudios Clínicos Latino América

    lead OTHER

Principal Investigators

  • María Luz Diaz, MD · ECLA- Estudios Clínicos Latino América

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2023-04-14
Completion
2023-06-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638009 on ClinicalTrials.gov